M. Vanmechelen

Cellular and molecular features related to exceptional therapy response and extreme long‐term survival in glioblastoma

R. Sciot, P. Agostinis, F. De Smet, 2023, Cancer medicine.

Fibroblast Growth Factor Receptor‐2 Polymorphism rs2981582 is Correlated With Progression‐free Survival and Overall Survival in Patients With Metastatic Clear‐cell Renal Cell Carcinoma Treated With Sunitinib

D. Lambrechts, J. Zucman‐Rossi, J. Machiels, 2019, Clinical genitourinary cancer.

Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome

P. Vandervoort, M. Vrolix, F. Verbrugge, 2015, European heart journal. Acute cardiovascular care.

Validation of the Correlation Between Single Nucleotide Polymorphism rs307826 in VEGFR3 and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Sunitinib

N. Rioux-Leclercq, D. Lambrechts, J. Zucman‐Rossi, 2020 .

Single‐cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma

K. Ligon, D. Lambrechts, F. De Smet, 2023, bioRxiv.

IL-1R signaling drives enteric glia-macrophage interaction in colorectal cancer progression

F. Smet, S. Tejpar, S. Wehner, 2023 .

IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer

F. Smet, G. Matteoli, S. Ibiza, 2023, bioRxiv.